Monitor for supplemental disclosures or press releases from Biogen regarding leadership changes. Absent details, this event should not drive trading decisions.
BIIB drugs
BIIB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 12 $184.10entry
- T+1 · 8mo ago −1.69%α −1.10% · $180.98
- T+5 · 8mo ago −0.66%α +0.32% · $182.88
- T+20 · 7mo ago −6.11%α −8.08% · $172.86
- T+60 · 5mo ago +6.11%α −4.59% · $195.34
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Item 5.02 disclosed, indicating a departure or appointment of directors or officers at Biogen Inc. (BIIB), but no details are available to assess the nature, participants, or implications of the change.
Key Facts
- Filing type is 8-K, indicating a material event.
- Item 5.02 reported: Departure or appointment of directors or officers.
- No document content available to determine who was involved, whether it was a resignation, retirement, or termination, or if a replacement was named.
Financial Impact
Not specified
Risk Factors
- Potential for unexpected executive turnover if the departure was involuntary or involved C-suite executives.
- Lack of transparency due to unavailable filing content limits ability to assess governance stability.
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
34 reports on BIIB
10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $251.65 −0.69% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $253.25 Now $251.65 −0.63% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $254.87 Now $251.65 −1.26% settles Feb 5
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 19, 202628d ago Press Release Neutral 4/10 Entry $233.48 Now $251.65 +7.78% settles Jan 14
- Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $251.65 +9.69% settles Jan 7
- Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $251.65 +14.45% settles Dec 29
- Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $251.65 +16.77% settles Dec 14
- Sep 3, 202610w ago Press Release Neutral 4/10 Entry $220.83 Now $251.65 +13.96% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers